The primary aim of the present PET study was to confirm previous results of decreased 5‐HT1A binding in AD patients and to further examine 5‐HT1A binding in subregions of the temporal lobe that have been implicated in the early neurodegenerative process of AD (Dubois et al., 2007). Here, HTR1A is linked to Alzheimer disease.